Urologix Inc. | Balance Sheet

Fiscal year is July-June. All values USD Thousands.
2010
2011
2012
2013
2014
Cash & Short Term Investments
5,702.00
3,061.00
1,899.00
2,290.00
718.00
Total Accounts Receivable
1,378.00
1,358.00
2,132.00
2,132.00
1,502.00
Inventories
1,498.00
1,127.00
1,448.00
1,952.00
1,397.00
Other Current Assets
139.00
249.00
290.00
128.00
63.00
Total Current Assets
8,717.00
5,795.00
5,769.00
6,502.00
3,680.00
Net Property, Plant & Equipment
1,014.00
861.00
862.00
735.00
471.00
Intangible Assets
123.00
102.00
5,377.00
4,623.00
1,370.00
Other Assets
349.00
5.00
668.00
667.00
146.00
Total Assets
10,203.00
6,763.00
12,676.00
12,527.00
5,667.00
ST Debt & Current Portion LT Debt
-
-
-
-
747.00
Accounts Payable
434.00
741.00
3,376.00
628.00
892.00
Income Tax Payable
191.00
188.00
-
126.00
79.00
Other Current Liabilities
1,372.00
828.00
3,913.00
1,883.00
2,574.00
Total Current Liabilities
1,997.00
1,757.00
7,289.00
2,637.00
4,292.00
Long-Term Debt
-
-
-
5,333.00
4,586.00
Deferred Taxes
-
-
35.00
36.00
-
Other Liabilities
-
160.00
4,726.00
4,101.00
3,766.00
Total Liabilities
1,997.00
1,917.00
12,050.00
12,107.00
12,644.00
Common Equity (Total)
8,206.00
4,846.00
626.00
420.00
6,977.00
Total Shareholders' Equity
8,206.00
4,846.00
626.00
420.00
6,977.00
Total Equity
8,206.00
4,846.00
626.00
420.00
6,977.00
Liabilities & Shareholders' Equity
10,203.00
6,763.00
12,676.00
12,527.00
5,667.00

About Urologix

View Profile
Address
14405 21st Avenue North
Minneapolis Minnesota 55447
United States
Employees -
Website -
Updated 07/08/2019
Urologix, Inc. develops, manufactures, markets and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia. The company was founded by Mitchell Dann and John M. Reid on May 29, 1991 and is headquartered in Minneapolis, MN.